-
Framework for Experimental Drug Use in Terminally Ill Patients
Terminally ill patients are often willing to try experimental therapies but are ineligible for clinical trials. A new framework offers strategies for access to experimental compounds, and attempts to balance the interests of patients, manufacturers, and society.
Medscape Medical News, January 2009
-
FDA Approves First Nucleic Acid Test to Screen for 2 Divergent HIV Types
The US Food and Drug Administration has approved the cobas TaqScreen MPX test for the presence of 2 divergent types of HIV in donated blood plasma and tissue.
Medscape Medical News, January 2009
-
Alternative Vaccine Schedule Stirs Debate
An article in Pediatrics criticizes a popular book on the timing of children's vaccines.
WebMD Health News, January 2009
-
Recalls & Warnings FDA Warns That Tinzaparin Increases Mortality Risk in Elderly Patients With Renal Insufficiency
A clinical study indicated that tinzaparin may lead to an increased risk for death in all renal-impaired elderly patients receiving tinzaparin.
Medscape Medical News, January 2009
-
CME/CE
Selective Digestive, Oropharyngeal Decontamination May Reduce Intensive Care Mortality
In an intensive care unit, mortality rate was reduced by 3.5 percentage points with selective digestive tract decontamination and by 2.9 percentage points with selective oropharyngeal decontamination.
Medscape Medical News, January 2009
-
CME
FDA Safety Changes: Clolar, Precedex, Treanda
The FDA has approved revisions to the safety labeling for clofarabine injection (Clolar), dexmedetomidine HCl injection (Precedex), and bendamustine HCl injection (Treanda).
Medscape Medical News, January 2009
-
FDA Safety Changes: Clolar, Precedex, Treanda
The FDA has approved revisions to the safety labeling for clofarabine injection (Clolar), dexmedetomidine HCl injection (Precedex), and bendamustine HCl injection (Treanda).
Medscape Medical News, January 2009
-
HPV-16 Oncoprotein Vaccine Protects Against Head and Neck Cancer in Mice
Immunization with a vaccine that targets the E6 and E7 oncoproteins of human papillomavirus-16 (HPV-16) prevents mice with HPV-16-positive head and neck squamous cell cancers (HNSCCs) from expressing these two oncoproteins by mounting a potent immune response.
Reuters Health Information, January 2009
-
Smoking Ban Lowers Heart Attacks in One US City
A smoking ban caused the incidence of MI to drop by more than 40% in one U.S. city and the decrease lasted 3 years, federal health experts reported on Wednesday.
Reuters Health Information, January 2009
-
Childhood and Adolescent Immunization Schedules Revised
The American Academy of Pediatrics, Advisory Committee on Immunization Practices, and American Academy of Family Physicians endorse the 2009 immunization recommendations.
Medscape Medical News, December 2008
-
Long-Term, Low-Dose Aspirin May Not Prevent Type 2 Diabetes in Healthy Women
In a randomized controlled trial, long-term low-dose aspirin did not prevent the development of clinical type 2 diabetes in initially healthy women.
Medscape Medical News, December 2008
-
CME
Long-Term, Low-Dose Aspirin May Not Prevent Type 2 Diabetes in Healthy Women
In a randomized controlled trial, long-term low-dose aspirin did not prevent the development of clinical type 2 diabetes in initially healthy women.
Medscape Medical News, December 2008
-
Selective Digestive, Oropharyngeal Decontamination May Reduce Intensive Care Mortality
In an intensive care unit, mortality rate was reduced by 3.5 percentage points with selective digestive tract decontamination and by 2.9 percentage points with selective oropharyngeal decontamination.
Medscape Medical News, December 2008
-
American Academy of Pediatrics Recommends Improved Health Plan Payment for Adolescents
The AAP recommends an improved health plan payment for adolescent preventive, reproductive, and behavioral care.
Medscape Medical News, December 2008
-
Supplementation With Vitamins C and E or Beta-Carotene May Not Prevent Cancer
In a double-blind, placebo-controlled trial, supplementation with vitamin C, vitamin E, or beta-carotene did not help in the primary prevention of total cancer incidence or cancer mortality.
Heartwire, December 2008
-
CME/CE
Self-Regulation Technique May Improve Physical Activity Level in Women
In a randomized controlled trial, women who learned a self-regulation technique during an information session were more physically active than women who participated in only the information session.
Medscape Medical News, December 2008
-
CME/CE
Supplementation With Vitamins C and E or Beta-Carotene May Not Prevent Cancer
In a double-blind, placebo-controlled trial, supplementation with vitamin C, vitamin E, or beta-carotene did not help in the primary prevention of total cancer incidence or cancer mortality.
Medscape Medical News, December 2008
-
Self-Regulation Technique May Improve Physical Activity Level in Women
In a randomized controlled trial, women who learned a self-regulation technique during an information session were more physically active than women who participated in only the information session.
Medscape Medical News, December 2008
-
Supplementation With Vitamins C and E or Beta-Carotene May Not Prevent Cancer
In a double-blind, placebo-controlled trial, supplementation with vitamin C, vitamin E, or beta-carotene did not help in the primary prevention of total cancer incidence or cancer mortality.
Medscape Medical News, December 2008
-
Traditional Risk Factors Do Not Explain Higher Stroke Mortality in "Stroke Belt"
While stroke mortality rates are approximately 50% higher than average among residents of the southeastern US -- the so-called "stroke belt" -- traditional risk factors contribute little to the excess mortality, a national longitudinal study indicates.
Reuters Health Information, December 2008
